SHANNON CHASE: Open Payments
NPI 1306320759 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,276 in 62 payments from 15 companies in 2025. Trend: 2023 $467 · 2024 $287 · 2025 $1,276
Food & beverage: $1,207Education: $69
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $496 |
| Incyte Corporation | 11 | $259 |
| Arcutis Biotherapeutics, Inc. | 16 | $147 |
| Organon LLC | 4 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| GENZYME CORPORATION | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| ABBVIE INC. | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $25 |
| UCB, Inc. | 1 | $22 |
Products named: TREMFYA, OPZELURA, Zoryve, DUPIXENT, VTAMA, Rhapsido, RINVOQ, Winlevi.
Industry payments across VA — which companies pay providers there.
